Fundz

Bardy Diagnostics, Inc. reported raising $35.5 Million in an initial SEC Form D filing, from an offering of $35.5 Million

PRIVATEApr 25, 2019

Amount Raised

$35.5 Million

$35.5 Million sold, per SEC Form D (first sale Apr 25, 2019)

Round Type

Venture

SeattleHealthcare

Who else raised in Healthcare around the same time

Companies in the same sectors as Bardy Diagnostics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Rennova Health, Inc. raised $125K (Seed) on June 7, 2019.
  • Three Oaks Hospice, Inc. raised $16M on June 7, 2019.
  • BRANCHPOINT TECHNOLOGIES raised $279K (Seed) on June 7, 2019.
  • Symplast Acquisition Inc. raised an undisclosed amount on June 6, 2019.
  • Deep Brain Innovations LLC raised $393K (Seed) on June 5, 2019.
  • Waveguide raised $2.6M on June 5, 2019.

Who to call at Bardy Diagnostics, Inc., and when

A new round usually means Bardy Diagnostics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Bardy Diagnostics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bardy Diagnostics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bardy Diagnostics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bardy Diagnostics, Inc.

Location

316 OCCIDENTAL AVENUE SOUTH

Seattle, Washington, United States

About

A revolution in heart monitoring is here. The Carnation Ambulatory Monitor (CAM™) is a lightweight, extended-wear ECG patch monitor that delivers unparalleled comfort, convenience, and clarity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bardy Diagnostics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Bardy Diagnostics, Inc.'s next move

See what Strategic adds

Bardy Diagnostics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.